US LAWS, STATUTES & CODES ON-LINE

US Supreme Court Decisions On-Line | US Laws



§ 350a. —  Infant formulas.



[Laws in effect as of January 24, 2002]
[Document not affected by Public Laws enacted between
  January 24, 2002 and December 19, 2002]
[CITE: 21USC350a]

 
                        TITLE 21--FOOD AND DRUGS
 
             CHAPTER 9--FEDERAL FOOD, DRUG, AND COSMETIC ACT
 
                           SUBCHAPTER IV--FOOD
 
Sec. 350a. Infant formulas


(a) Adulteration

    An infant formula, including an infant formula powder, shall be 
deemed to be adulterated if--
        (1) such infant formula does not provide nutrients as required 
    by subsection (i) of this section,
        (2) such infant formula does not meet the quality factor 
    requirements prescribed by the Secretary under subsection (b)(1) of 
    this section, or
        (3) the processing of such infant formula is not in compliance 
    with the good manufacturing practices and the quality control 
    procedures prescribed by the Secretary under subsection (b)(2) of 
    this section.

(b) Requirements for quality factors, good manufacturing practices, and 
        retention of records

    (1) The Secretary shall by regulation establish requirements for 
quality factors for infant formulas to the extent possible consistent 
with current scientific knowledge, including quality factor requirements 
for the nutrients required by subsection (i) of this section.
    (2)(A) The Secretary shall by regulation establish good 
manufacturing practices for infant formulas, including quality control 
procedures that the Secretary determines are necessary to assure that an 
infant formula provides nutrients in accordance with this subsection and 
subsection (i) of this section and is manufactured in a manner designed 
to prevent adulteration of the infant formula.
    (B) The good manufacturing practices and quality control procedures 
prescribed by the Secretary under subparagraph (A) shall include 
requirements for--
        (i) the testing, in accordance with paragraph (3) and by the 
    manufacturer of an infant formula or an agent of such manufacturer, 
    of each batch of infant formula for each nutrient required by 
    subsection (i) of this section before the distribution of such 
    batch,
        (ii) regularly scheduled testing, by the manufacturer of an 
    infant formula or an agent of such manufacturer, of samples of 
    infant formulas during the shelf life of such formulas to ensure 
    that such formulas are in compliance with this section,
        (iii) in-process controls including, where necessary, testing 
    required by good manufacturing practices designed to prevent 
    adulteration of each batch of infant formula, and
        (iv) the conduct by the manufacturer of an infant formula or an 
    agent of such manufacturer of regularly scheduled audits to 
    determine that such manufacturer has complied with the regulations 
    prescribed under subparagraph (A).

In prescribing requirements for audits under clause (iv), the Secretary 
shall provide that such audits be conducted by appropriately trained 
individuals who do not have any direct responsibility for the 
manufacture or production of infant formula.
    (3)(A) At the final product stage, each batch of infant formula 
shall be tested for vitamin A, vitamin B1, vitamin C, and vitamin E to 
ensure that such infant formula is in compliance with the requirements 
of this subsection and subsection (i) of this section relating to such 
vitamins.
    (B) Each nutrient premix used in the manufacture of an infant 
formula shall be tested for each relied upon nutrient required by 
subsection (i) of this section which is contained in such premix to 
ensure that such premix is in compliance with its specifications or 
certifications by a premix supplier.
    (C) During the manufacturing process or at the final product stage 
and before distribution of an infant formula, an infant formula shall be 
tested for all nutrients required to be included in such formula by 
subsection (i) of this section for which testing has not been conducted 
pursuant to subparagraph (A) or (B). Testing under this subparagraph 
shall be conducted to--
        (i) ensure that each batch of such infant formula is in 
    compliance with the requirements of subsection (i) of this section 
    relating to such nutrients, and
        (ii) confirm that nutrients contained in any nutrient premix 
    used in such infant formula are present in each batch of such infant 
    formula in the proper concentration.

    (D) If the Secretary adds a nutrient to the list of nutrients in the 
table in subsection (i) of this section, the Secretary shall by 
regulation require that the manufacturer of an infant formula test each 
batch of such formula for such new nutrient in accordance with 
subparagraph (A), (B), or (C).
    (E) For purposes of this paragraph, the term ``final product stage'' 
means the point in the manufacturing process, before distribution of an 
infant formula, at which an infant formula is homogenous and is not 
subject to further degradation.
    (4)(A) The Secretary shall by regulation establish requirements 
respecting the retention of records. Such requirements shall provide 
for--
        (i) the retention of all records necessary to demonstrate 
    compliance with the good manufacturing practices and quality control 
    procedures prescribed by the Secretary under paragraph (2), 
    including records containing the results of all testing required 
    under paragraph (2)(B),
        (ii) the retention of all certifications or guarantees of 
    analysis by premix suppliers,
        (iii) the retention by a premix supplier of all records 
    necessary to confirm the accuracy of all premix certifications and 
    guarantees of analysis,
        (iv) the retention of--
            (I) all records pertaining to the microbiological quality 
        and purity of raw materials used in infant formula powder and in 
        finished infant formula, and
            (II) all records pertaining to food packaging materials 
        which show that such materials do not cause an infant formula to 
        be adulterated within the meaning of section 342(a)(2)(C) of 
        this title,

        (v) the retention of all records of the results of regularly 
    scheduled audits conducted pursuant to the requirements prescribed 
    by the Secretary under paragraph (2)(B)(iv), and
        (vi) the retention of all complaints and the maintenance of 
    files with respect to, and the review of, complaints concerning 
    infant formulas which may reveal the possible existence of a hazard 
    to health.

    (B)(i) Records required under subparagraph (A) with respect to an 
infant formula shall be retained for at least one year after the 
expiration of the shelf life of such infant formula. Except as provided 
in clause (ii), such records shall be made available to the Secretary 
for review and duplication upon request of the Secretary.
    (ii) A manufacturer need only provide written assurances to the 
Secretary that the regularly scheduled audits required by paragraph 
(2)(B)(iv) are being conducted by the manufacturer, and need not make 
available to the Secretary the actual written reports of such audits.

(c) Registration of persons distributing new infant formula

    (1) No person shall introduce or deliver for introduction into 
interstate commerce any new infant formula unless--
        (A) such person has, before introducing such new infant formula, 
    or delivering such new infant formula for introduction, into 
    interstate commerce, registered with the Secretary the name of such 
    person, the place of business of such person, and all establishments 
    at which such person intends to manufacture such new infant formula, 
    and
        (B) such person has at least 90 days before marketing such new 
    infant formula, made the submission to the Secretary required by 
    subsection (c)(1) of this section.

    (2) For purposes of paragraph (1), the term ``new infant formula'' 
includes--
        (A) an infant formula manufactured by a person which has not 
    previously manufactured an infant formula, and
        (B) an infant formula manufactured by a person which has 
    previously manufactured infant formula and in which there is a major 
    change, in processing or formulation, from a current or any previous 
    formulation produced by such manufacturer.

For purposes of this paragraph, the term ``major change'' has the 
meaning given to such term in section 106.30(c)(2) of title 21, Code of 
Federal Regulations (as in effect on August 1, 1986), and guidelines 
issued thereunder.

(d) Submission of information about new infant formula required

    (1) A person shall, with respect to any infant formula subject to 
subsection (c) of this section, make a submission to the Secretary which 
shall include--
        (A) the quantitative formulation of the infant formula,
        (B) a description of any reformulation of the formula or change 
    in processing of the infant formula,
        (C) assurances that the infant formula will not be marketed 
    unless it meets the requirements of subsections (b)(1) and (i) of 
    this section, as demonstrated by the testing required under 
    subsection (b)(3) of this section, and
        (D) assurances that the processing of the infant formula 
    complies with subsection (b)(2) of this section.

    (2) After the first production of an infant formula subject to 
subsection (c) of this section, and before the introduction into 
interstate commerce of such formula, the manufacturer of such formula 
shall submit to the Secretary, in such form as may be prescribed by the 
Secretary, a written verification which summarizes test results and 
records demonstrating that such formula complies with the requirements 
of subsections (b)(1), (b)(2)(A), (b)(2)(B)(i), (b)(2)(B)(iii), 
(b)(3)(A), (b)(3)(C), and (i) of this section.
    (3) If the manufacturer of an infant formula for commercial or 
charitable distribution for human consumption determines that a change 
in the formulation of the formula or a change in the processing of the 
formula may affect whether the formula is adulterated under subsection 
(a) of this section, the manufacturer shall, before the first processing 
of such formula, make the submission to the Secretary required by 
paragraph (1).

(e) Additional notice requirements for manufacturer

    (1) If the manufacturer of an infant formula has knowledge which 
reasonably supports the conclusion that an infant formula which has been 
processed by the manufacturer and which has left an establishment 
subject to the control of the manufacturer--
        (A) may not provide the nutrients required by subsection (i) of 
    this section, or
        (B) may be otherwise adulterated or misbranded,

the manufacturer shall promptly notify the Secretary of such knowledge. 
If the Secretary determines that the infant formula presents a risk to 
human health, the manufacturer shall immediately take all actions 
necessary to recall shipments of such infant formula from all wholesale 
and retail establishments, consistent with recall regulations and 
guidelines issued by the Secretary.
    (2) For purposes of paragraph (1), the term ``knowledge'' as applied 
to a manufacturer means (A) the actual knowledge that the manufacturer 
had, or (B) the knowledge which a reasonable person would have had under 
like circumstances or which would have been obtained upon the exercise 
of due care.

(f) Procedures applicable to recalls by manufacturer; regulatory 
        oversight

    (1) If a recall of infant formula is begun by a manufacturer, the 
recall shall be carried out in accordance with such requirements as the 
Secretary shall prescribe under paragraph (2) and--
        (A) the Secretary shall, not later than the 15th day after the 
    beginning of such recall and at least once every 15 days thereafter 
    until the recall is terminated, review the actions taken under the 
    recall to determine whether the recall meets the requirements 
    prescribed under paragraph (2), and
        (B) the manufacturer shall, not later than the 14th day after 
    the beginning of such recall and at least once every 14 days 
    thereafter until the recall is terminated, report to the Secretary 
    the actions taken to implement the recall.

    (2) The Secretary shall by regulation prescribe the scope and extent 
of recalls of infant formulas necessary and appropriate for the degree 
of risks to human health presented by the formula subject to the recall.
    (3) The Secretary shall by regulation require each manufacturer of 
an infant formula who begins a recall of such formula because of a risk 
to human health to request each retail establishment at which such 
formula is sold or available for sale to post at the point of purchase 
of such formula a notice of such recall at such establishment for such 
time that the Secretary determines necessary to inform the public of 
such recall.

(g) Recordkeeping requirements for manufacturer; regulatory oversight 
        and enforcement

    (1) Each manufacturer of an infant formula shall make and retain 
such records respecting the distribution of the infant formula through 
any establishment owned or operated by such manufacturer as may be 
necessary to effect and monitor recalls of the formula. Such records 
shall be retained for at least one year after the expiration of the 
shelf life of the infant formula.
    (2) To the extent that the Secretary determines that records are not 
being made or maintained in accordance with paragraph (1), the Secretary 
may by regulation prescribe the records required to be made under 
paragraph (1) and requirements respecting the retention of such records 
under such paragraph. Such regulations shall take effect on such date as 
the Secretary prescribes but not sooner than the 180th day after the 
date such regulations are promulgated. Such regulations shall apply only 
with respect to distributions of infant formulas made after such 
effective date.

(h) Exemptions; regulatory oversight

    (1) Any infant formula which is represented and labeled for use by 
an infant--
        (A) who has an inborn error of metabolism or a low birth weight, 
    or
        (B) who otherwise has an unusual medical or dietary problem,

is exempt from the requirements of subsections (a), (b), and (c) of this 
section. The manufacturer of an infant formula exempt under this 
paragraph shall, in the case of the exempt formula, be required to 
provide the notice required by subsection (e)(1) of this section only 
with respect to adulteration or misbranding described in subsection 
(e)(1)(B) of this section and to comply with the regulations prescribed 
by the Secretary under paragraph (2).
    (2) The Secretary may by regulation establish terms and conditions 
for the exemption of an infant formula from the requirements of 
subsections (a), (b), and (c) of this section. An exemption of an infant 
formula under paragraph (1) may be withdrawn by the Secretary if such 
formula is not in compliance with applicable terms and conditions 
prescribed under this paragraph.

(i) Nutrient requirements

    (1) An infant formula shall contain nutrients in accordance with the 
table set out in this subsection or, if revised by the Secretary under 
paragraph (2), as so revised.
    (2) The Secretary may by regulation--
        (A) revise the list of nutrients in the table in this 
    subsection, and
        (B) revise the required level for any nutrient required by the 
    table.

                                NUTRIENTS
------------------------------------------------------------------------
           Nutrient                          Minimum a       Maximum a
------------------------------------------------------------------------
Protein (gm)..................     1.8 b  ...............    4.5.
Fat:
  gm..........................     3.3    ...............    6.0.
  percent cal.................    30.0    ...............   54.0.
Essential fatty acids
 (linoeate):
  percent cal.................     2.7    ...............  .............
  mg..........................   300.0    ...............  .............
Vitamins:
  A (IU)......................   250.0    (75 mg)c.......  750.0 (225
                                                            mg).c
  D (IU)......................    40.0    ...............  100.0.
  K (mg)......................     4.0    ...............  .............
  E (IU)......................     0.7    (with 0.7 IU/gm  .............
                                           linoleic acid).
  C (ascorbic acid) (mg)......     8.0    ...............  .............
  B1 (thiamine) (mg)..........    40.0    ...............  .............
  B2 (riboflavin) (mg)........    60.0    ...............  .............
  B6 (pyridoxine) (mg)........    35.0    (with 15 mg/gm   .............
                                           of protein in
                                           formula).
  B12 (mg)....................     0.15   ...............  .............
  Niacin (mg).................   250.0    ...............  .............
  Folic acid (mg).............     4.0    ...............  .............
  Pantothenic acid (mg).......   300.0    ...............  .............
  Biotin (mg).................     1.5 d  ...............  .............
  Choline (mg)................     7.0 d  ...............  .............
  Inositol (mg)...............     4.0 d  ...............  .............
Minerals:
  Calcium (mg)................    50.0 e  ...............  .............
  Phosphorus (mg).............    25.0 e  ...............  .............
  Magnesium (mg)..............     6.0    ...............  .............
  Iron (mg)...................     0.15   ...............  .............
  Iodine (mg).................     5.0    ...............  .............
  Zinc (mg)...................     0.5    ...............  .............
  Copper (mg).................    60.0    ...............  .............
  Manganese (mg)..............     5.0    ...............  .............
  Sodium (mg).................    20.0    ...............   60.0.
  Potassium (mg)..............    80.0    ...............  200.0.
  Chloride (mg)...............    55.0    ...............  150.0.
------------------------------------------------------------------------
a Stated per 100 kilocalories.
b The source of protein shall be at least nutritionally equivalent to
  casein.
c Retinol equivalents.
d Required to be included in this amount only in formulas which are not
  milk-based.
e Calcium to phosphorus ratio must be no less than 1.1 nor more than
  2.0.

(June 25, 1938, ch. 675, Sec. 412, as added Pub. L. 96-359, Sec. 2, 
Sept. 26, 1980, 94 Stat. 1190; amended Pub. L. 99-570, title IV, 
Sec. 4014(a), (b)(1), Oct. 27, 1986, 100 Stat. 3207-116, 3207-120; Pub. 
L. 103-80, Sec. 3(l), Aug. 13, 1993, 107 Stat. 777.)


                               Amendments

    1993--Subsec. (h)(1). Pub. L. 103-80 substituted ``(e)(1)(B) of this 
section'' for ``(c)(1)(B) of this section,'' in concluding provisions.
    1986--Subsecs. (a) to (d). Pub. L. 99-570, Sec. 4014(a)(7), added 
subsecs. (a) to (d) and struck out former subsecs. (a) relating to 
adulteration and regulatory oversight, (b) relating to notice to the 
Secretary by a manufacturer and requirements and scope of that notice, 
(c) relating to additional notice requirements for the manufacturer, and 
(d) relating to procedures applicable to recalls by a manufacturer.
    Subsecs. (e), (f). Pub. L. 99-570, Sec. 4014(a)(1), (7), added 
subsecs. (e) and (f) and redesignated former subsecs. (e) and (f) as (g) 
and (h), respectively.
    Subsec. (g). Pub. L. 99-570, Sec. 4014(a)(1), (2), redesignated 
subsec. (e) as (g) and substituted ``Such records shall be retained for 
at least one year after the expiration of the shelf life of the infant 
formula'' for ``No manufacturer shall be required under this subsection 
to retain any record respecting the distribution of an infant formula 
for a period of longer than 2 years from the date the record was made''. 
Former subsec. (g) redesignated (i).
    Subsec. (h). Pub. L. 99-570, Sec. 4014(a)(1), redesignated subsec. 
(f) as (h).
    Subsec. (h)(1). Pub. L. 99-570, Sec. 4014(a)(3), (4), substituted 
``(a), (b), and (c)'' for ``(a) and (b)'' and ``(e)(1)'' for ``(c)(1)''.
    Pub. L. 99-570, Sec. 4014(a)(5), which directed that ``(d)(1)(B)'' 
be substituted for ``(e)(1)(B)'' in second sentence could not be 
executed because ``(e)(1)(B)'' did not appear. See 1993 Amendment note 
above.
    Subsec. (h)(2). Pub. L. 99-570, Sec. 4014(a)(6), substituted ``(a), 
(b), and (c)'' for ``(a) and (b)''.
    Subsec. (i). Pub. L. 99-570, Sec. 4014(a)(1), (b)(1), redesignated 
subsec. (g) as (i), designated existing provisions as par. (1), 
substituted ``paragraph (2)'' for ``subsection (a)(2) of this section'', 
substituted a period for the colon after ``as so revised'', and added 
par. (2).


                    Effective Date of 1980 Amendment

    Section 6 of Pub. L. 96-359 provided that: ``Section 412 of the 
Federal Food, Drug, and Cosmetic Act (added by section 2) [this section] 
shall apply with respect to infant formulas manufactured on or after the 
90th day after the date of the enactment of this Act [Sept. 26, 1980].''

                  Section Referred to in Other Sections

    This section is referred to in sections 331, 343, 374 of this title.



chanrobles.com.Com


ChanRobles Legal Resources:

ChanRobles On-Line Bar Review

ChanRobles Internet Bar Review : www.chanroblesbar.com

ChanRobles MCLE On-line

ChanRobles Lawnet Inc. - ChanRobles MCLE On-line : www.chanroblesmcleonline.com